The Effectiveness of Culturally Adapted Cognitive Behavioral Intervention Among COVID-19 Survivors
Culturally Adapted Cognitive Behavioral Intervention to Reduce Psychological Distress Among COVID-19 Survivors: A Randomized Controlled Trial
1 other identifier
interventional
34
1 country
1
Brief Summary
The effectiveness study for Culturally-Adapted Cognitive Behavioral Intervention (CA-CBI) will be conducted with individuals infected with and recovered from Coronavirus disease (COVID-19) to measure if this intervention is effective in decreasing the COVID-19 survivors' psychological distress. Potential participants will be given an informed consent and then, they will be included in a screening procedure to assess their eligibility. 86 participants (43 in experimental and 43 in control group-randomly assigned) who pass the screening procedure will be invited to the effectiveness study. The experimental group will receive an 8-session intervention while the control group will receive a brief psychoeducation about problems during COVID-19 pandemic and information about the freely available psychological support options. The measurements will be conducted three times; one week before, one week after and five weeks after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 2, 2021
CompletedStudy Start
First participant enrolled
November 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJune 30, 2022
July 1, 2021
4 months
July 1, 2021
June 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of changes of the Kessler-10 Psychological Distress Scale (K10) over time
Kessler-10 Psychological Distress Scale is a 10-item scale that aims to measure the psychological distress. Each item is scored from 1 (none of the time) to 5 (all of the time) providing a range between 10 and 50. Higher scores indicate more severe psychological distress.
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Secondary Outcomes (5)
Comparison of changes of the Patient Health Questionnaire-9 (PHQ-9) over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Comparison of changes of the General Anxiety Disorder-7 (GAD-7) over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Comparison of changes of the PTSD Checklist for The Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) (PCL-5) over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Comparison of changes of the Symptom Checklist 90-R (SCL-90-R) Somatization Subscale over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Comparison of changes of the World Health Organization Quality of Life Scale (WHOQOL Bref) over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Other Outcomes (2)
Comparison of changes of the Psychological Flexibility Scale over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Comparison of changes of the Emotion Regulation Questionnaire over time
Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)
Study Arms (2)
Intervention Arm: Culturally Adapted Cognitive Behavioral Intervention (CA-CBI)
EXPERIMENTALThe experimental group will receive an 8-session CA-CBI in an online group format.
Control Arm: Enhanced Treatment as Usual (ETA-U)
OTHERThe control group will receive the information about freely available psychological support options. Also, they will receive brief psychoeducation about the mental health problems and psychological distress via online leaflets. After all the measurements are completed, the control group will be able to receive the CA-CBI.
Interventions
CA-CBI is an intervention based on Culturally Adapted Cognitive Behavioral Therapy (CA-CBT) which was developed by Devon Hinton. This trans-diagnostic intervention has a structured manual which can be culturally adapted and it will be used to decrease psychological distress and increase quality of life by targeting cognitive and behavioral changes.
Participants who receive ETAU will be provided a brief psychoeducation via online leaflets and will be informed about centers where they can receive free psychosocial support.
Eligibility Criteria
You may qualify if:
- Being 18 years or above
- Getting infected with COVID-19 and currently, recovered
- Scoring 16 or above on Kessler Psychological Distress Scale (K10)
You may not qualify if:
- Imminent suicidal risk
- Having a severe psychiatric disorder (psychotic disorders, acute mania, substance/alcohol addiction, cluster B personality disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Koç Universitylead
Study Sites (1)
Koc University
Istanbul, Turkey (Türkiye)
Related Publications (7)
Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - A systematic review and meta-analysis. Psychiatry Res. 2020 Sep;291:113190. doi: 10.1016/j.psychres.2020.113190. Epub 2020 Jun 7.
PMID: 32563745BACKGROUNDAcarturk ZC, Abuhamdeh S, Jalal B, Unaldi N, Alyanak B, Cetinkaya M, Gulen B, Hinton D. Culturally adapted transdiagnostic CBT for SSRI resistant Turkish adolescents: A pilot study. Am J Orthopsychiatry. 2019;89(2):222-227. doi: 10.1037/ort0000310. Epub 2018 Jan 18.
PMID: 29345479BACKGROUNDKananian S, Soltani Y, Hinton D, Stangier U. Culturally Adapted Cognitive Behavioral Therapy Plus Problem Management (CA-CBT+) With Afghan Refugees: A Randomized Controlled Pilot Study. J Trauma Stress. 2020 Dec;33(6):928-938. doi: 10.1002/jts.22615. Epub 2020 Nov 5.
PMID: 33155348BACKGROUNDHinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct;17(5):429-33. doi: 10.1023/B:JOTS.0000048956.03529.fa.
PMID: 15633922BACKGROUNDYue JL, Yan W, Sun YK, Yuan K, Su SZ, Han Y, Ravindran AV, Kosten T, Everall I, Davey CG, Bullmore E, Kawakami N, Barbui C, Thornicroft G, Lund C, Lin X, Liu L, Shi L, Shi J, Ran MS, Bao YP, Lu L. Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review. Psychol Med. 2020 Nov;50(15):2498-2513. doi: 10.1017/S0033291720003888. Epub 2020 Nov 5.
PMID: 33148347BACKGROUNDTaquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021 May;8(5):416-427. doi: 10.1016/S2215-0366(21)00084-5. Epub 2021 Apr 6.
PMID: 33836148BACKGROUNDWang Y, Kala MP, Jafar TH. Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis. PLoS One. 2020 Dec 28;15(12):e0244630. doi: 10.1371/journal.pone.0244630. eCollection 2020.
PMID: 33370404BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Talya Öztürk, BA
Koç University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 2, 2021
Study Start
November 17, 2021
Primary Completion
March 28, 2022
Study Completion
April 1, 2022
Last Updated
June 30, 2022
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share